swissnex Startup Bootcamps

Empowering Swiss Startups to Internationalize.

Startups


Empowering Swiss Startups to Internationalize

 

swissnex is the launchpad for Swiss startups in the US. Our equity-free startup programs are customized to the needs of entrepreneurs exploring or entering the US market. With over a decade of experience accelerating the international success of companies such as Mindmaze, faceshift, and Ava, we tailor our toolbox sessions to each startup and offer critical business connections. By joining our community of innovators, Swiss startups gain visibility and a home base to succeed in the US.

Twice a year, swissnex brings together promising Swiss Startups for a two week bootcamp with toolbox sessions, fireside chats, special networking events, a demo night, and more. However it is possible to come to swissnex SF year-round, just indicate your preferred dates in the application.

 

 

Applying startups need to be in the
Innosuisse coaching program

Next Startup Bootcamp:

October 12-23, 2020 (application deadline July 31th)  – Health Focus

Missed the deadline? Reach out to startups@nullswissnexsf.org to see if you still can get into the program.


Participants of the virtual October 2020 bootcamp

ASPIVIX | Mathieu HORRAS, Co-founder & CEO | aspivix.com

Every year, more than 80M women worldwide experience pain, bleeding and tissue tear when undergoing common gynecological procedures that require uterus access. This trauma is generated by the Cervical Tenaculum, an instrument with sharp hooks that pinch the cervix to generate traction. ASPIVIX is changing that by developing a next-generation vacuum-based cervical device that delivers the same maneuverability as the tenaculum without the reported patient trauma. This device is ideal to help address unplanned pregnancies, considered one of the most significant global public health issues, by increasing the adoption of Intrauterine Contraceptive Devices (IUD), the most effective reversible contraceptive option available today. ASPIVIX empowers women and makes them free to choose their contraception option without fear. Find them on Facebook, Instagram, Linkedin, Twitter, and YouTube.


Auxivo AG
| Volker Bartenbach, Co-founder & CEO.  Michael Stucky, Co-founder & Chairman. Fabio Gobbo, Business Developer | auxivo.com

Auxivo is a spinoff from ETH Zurich developing the next generation of lightweight exoskeletons to improve workers‘ lives. Follow them on Facebook, Instagram, Linkedin, and Twitter.

JAMIE & I | Antonia Bolla, Founder | jamieandi.shop

Welcome to Your Personal Online Boutique with Sustainable Designers you’ll LOVE! Curated by Jamie, your personal artificially intelligent online stylist who curates your personal online boutique with a curated selection of sustainable designers tailored to your style. Follow them on Instagram, and Linkedin.

MYLEG | Giacomo Valle, Postdoctoral Researcher at ETHZ | p3.snf.ch

MYLEG is a non-invasive sensory feedback to improve Mobility and to promote cognitive prosthesis integration in people with leg amputation.

Neurosoft Bioelectronics | Nicolas Vachicouras, CEO & Karsten Bagger, CBO | neurosoft-bio.com

Neurosoft Bioelectronics develops implantable medical devices to interface with the brain and spinal cord to treat patients suffering from neurological disorders. Our main USP is that we are the only ones to have been able to combine extremely soft materials that match the mechanical properties of the nervous tissues with high-density electrodes. Thanks to these unique features, we can access some locations of the brain that are impossible to reach surgically otherwise. Our preliminary animal data also suggest that our soft electrodes reduce dramatically inflammation when implanted. Follow them on Linkedin and Twitter.

Optimo Medical AG | Harald P. Studer, CEO & Alexander van der Mey, CCO | optimo-medical.com

Optimo Medical AG is specialized in bio-mechanical analyses and simulation of the anterior eye. Since the companies founding in 2015, the team has built a steady reputation as the leading company in virtual trials for the anterior eye segment, and a global technology leader in patient specific astigmatism management. Follow them on Linkedin.

Scailyte | Peter Nestorov, CEO. Stefan Almestrand, Director Corporate Development. Andrius Serva, Business Development Manager. Agnieszka Sitarska, Business Development Associate | scailyte.com

Scailyte uses single cell technologies and AI to discover biomarkers for diseases in oncology and immunology. We have a number of patented biomarker signatures which we currently are developing into clinical diagnostic applications for hospitals and subsequently patients. Follow them on Linkedin.

 


What We Offer

 

 

 


Since 2010, we’ve supported 98 Swiss startups.

We integrate a community of over 400 founders and organizations.

Our startup alumni have a combined valuation of $1.1B, and have created more than 500 jobs.


In the press

A digital bootcamp for seven Swiss startups to explore the US market (Startupticker.ch – May 12, 2020)
A San Francisco startup guide for international entrepreneurs (Podium – August 13, 2019)
swissnex Startup Bootcamp: Off to San Francisco (Startupticker.ch – August 7, 2019)
Go Global: The swissnex Startup Roadshow in Switzerland (Startupticker.ch – May 14, 2019)
swissnex SF on CNN Money Switzerland (CNN – May 6, 2019)


Coaches & Speakers

Organizers

 

  • Franziska Steiner, organizer, swissnexSF
  • Linda Aerne, organizer, swissnexSF

Partners

Swiss Community

Startupticker.ch | The Swiss Startup News channel Startupticker.ch | The Swiss Startup News channel Atom-Feed: News

  • UBS plans to invest USD 200 million in digital ventures
    by Startupticker on October 27, 2020 at 9:27 am

    The UBS Next portfolio is an additional step for UBS to further engage with fintechs and the broader tech ecosystem. UBS Next primarily pursues direct investments into early stage fintechs and other relevant tech companies. Several direct investments are in evaluation.

  • INVOLI collaborates successfully with a Canadian partner
    by Startupticker on October 26, 2020 at 8:28 am

    INVOLI has entered into a partnership with AirMarket following the successful collaboration during an official Canadian trial. The trial aimed at generating data for future regulations and delivering commercial cellular-enabled unmanned traffic management (UTM) services. The goal of the two companies is to offer integrated services to the drone market, in Canada and beyond.

  • Worldwide recognition for Swiss cleantech and deeptech solutions
    by Startupticker on October 22, 2020 at 1:06 pm

    Awards and recognition prizes come in different forms. In recent global competitions, two Swiss start-ups were recognised for their achievements, while three were selected to join incubation and acceleration programs to hasten product development.

  • Idorsia completes capital increase of CHF 535.5 million
    by Startupticker on October 22, 2020 at 7:53 am

    The increased liquidity will be used to prepare for the launch of its first product for the treatment of insomnia and further fund Idorsia’s diversified pipeline.

  • A CHF 15.2 Million seed investment brings Araris Biotech a step further
    by Startupticker on October 22, 2020 at 6:42 am

    Araris Biotech has obtained additional CHF 12.7 million in its seed financing round, bringing the total amount raised to CHF 15.2 million. Led by Pureos Bioventures proceeds from the round will enable Araris to advance its lead antibody-drug conjugates (ADCs) into preclinical and clinical development.